OTC Drug Compliance Knowledge Base
Practical guides for OTC manufacturers and sellers covering 21 CFR 211, NDC/listing, Drug Facts, monographs and adverse-event reporting.
Back to OTC industry hubAll Practical Guides
This topic index gathers all practical guides for the segment, organised around common customer questions.
U.S. 21 CFR 211 Finished Pharmaceutical GMP & FDA Inspection Guide
In-depth review of 21 CFR 211 regulations for finished OTC drugs, covering quality control units, batch records, deviations, and computer validations.
U.S. FDA Drug Establishment Registration & NDC Barcode Listing Guide
Guiding OTC manufacturers through FDA portals for facility listing, obtaining DUNS, requesting National Drug Codes (NDC), and XML SPL submissions.
U.S. OTC Drug Facts Label Layout & Claims Guidelines
Interpreting US 21 CFR Part 201 labeling laws, detailing mandatory Drug Facts formatting, font criteria, active/inactive lists, and claim controls.
Amazon OTC Drug Take-down Analysis & POA Appeal Guide
For Amazon US sellers, evaluating listing blocks due to "Unapproved New Drugs," restricted products, or misbranding, with POA drafting tips.
OTC Drug Stability Program & Shelf Life Determination Requirements
Introducing FDA requirements for finished OTC stability programs, testing parameters, active assay decay, and shelf-life calculations.
OTC Brand Owner Supplier GMP Audit Checklist for CMO/CDMO Facilities
Providing CMO/CDMO auditing guidelines for OTC brands, detailing 21 CFR 211 compliance checks, batch release systems, and quality agreements.
U.S. FDA OTC Drug Monograph vs NDA Regulatory Pathway Selection
Analyzing FDA’s dual pathways for OTC registration, guiding manufacturers to verify monograph exemptions or if an NDA submission is required.
OTC Finished Formulation Process Validation & Cleaning Validation Guide
Introducing the three stages of process validation and calculating cleaning validation residue limits using toxicology thresholds (ADE/PDE).
Non-Sterile Drug Microbial Control & Purified Water Monitoring
Analyzing microbial limits for non-sterile formulations (creams, gels, syrups) per USP <61> & <62>, pathogen screen, and purified water monitoring.
OTC Drug Recall Management & Adverse Event Reporting System (AERS) Guidelines
Mapping FDA FAERS reporting deadlines (15-day alert reports), PADER files, and mock recall testing procedures for OTC brand owners.
